| Financial Year |
March 31 2023 |
| Monetary Funds |
490,424,451.69 |
| Held-for-trading Financial Assets |
108,361,219.95 |
| Notes Receivable |
-- |
| Accounts Receivable |
261,733,390.45 |
| Advances to Suppliers |
17,764,987.51 |
| Other Receivables |
6,156,169.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,054,540.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
38,408,173.39 |
| Other Current Assets |
8,050,795.36 |
| Total Current Assets |
1,004,064,014.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
234,179.50 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,628,409.49 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,805,566.59 |
| R&D expenses |
-- |
| Goodwill |
2,682,094.38 |
| Long-Term Deferred and Prepaid Expenses |
746,127.98 |
| Deferred Income Tax Assets |
15,241,876.06 |
| Other Non-Current Assets |
3,139,253.53 |
| Sub-Total of Non-Current Assets |
37,713,352.42 |
| Total Assets |
1,041,777,367.09 |
| Short-Term Loans |
34,603,195.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,151,266.70 |
| Accounts Payable |
54,457,681.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,541,766.69 |
| Taxes Payable |
34,839,439.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,820,592.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,319,391.10 |
| Other Current Liabilities |
17,600,000.00 |
| Sub-Total of Current Liabilities |
194,908,584.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,884,393.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,069,960.66 |
| Total Liabilities |
205,978,545.03 |
| Paid-In Capital(Or Share Stock) |
65,956,800.00 |
| Capital Surplus |
572,219,716.72 |
| Surplus Reserve |
25,904,440.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
171,979,344.73 |
| Minority Stockholder's Interest |
-318,214.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
836,117,036.47 |
| Owner's Equity（Stockholder's Equity） |
835,798,822.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,041,777,367.09 |
